MA29238B1 - Synthese de taurine, production et utilisation de celle-ci comme medicament - Google Patents
Synthese de taurine, production et utilisation de celle-ci comme medicamentInfo
- Publication number
- MA29238B1 MA29238B1 MA30110A MA30110A MA29238B1 MA 29238 B1 MA29238 B1 MA 29238B1 MA 30110 A MA30110 A MA 30110A MA 30110 A MA30110 A MA 30110A MA 29238 B1 MA29238 B1 MA 29238B1
- Authority
- MA
- Morocco
- Prior art keywords
- taurine
- production
- medicinal product
- salts
- quantitative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
- C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
- C07C323/59—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton with acylated amino groups bound to the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C309/13—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C309/13—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
- C07C309/14—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EG2005010013 | 2005-01-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA29238B1 true MA29238B1 (fr) | 2008-02-01 |
Family
ID=36647837
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA30110A MA29238B1 (fr) | 2005-01-05 | 2007-07-26 | Synthese de taurine, production et utilisation de celle-ci comme medicament |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP1844006A2 (pt) |
JP (1) | JP2008526789A (pt) |
KR (1) | KR20070091198A (pt) |
CN (1) | CN101146767A (pt) |
AP (1) | AP2007004084A0 (pt) |
AU (1) | AU2005324199A1 (pt) |
BR (1) | BRPI0519606A2 (pt) |
CA (1) | CA2593563A1 (pt) |
EA (1) | EA200701434A1 (pt) |
IL (1) | IL184221A0 (pt) |
MA (1) | MA29238B1 (pt) |
MX (1) | MX2007008196A (pt) |
NO (1) | NO20074937A (pt) |
TN (1) | TNSN07226A1 (pt) |
WO (1) | WO2006072259A2 (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20100091219A (ko) | 2007-11-30 | 2010-08-18 | 더 리전트 오브 더 유니버시티 오브 캘리포니아 | 시스테아민 산물을 이용한 비-알코올성 지방성간염(nash) 치료 방법 |
CN103382170B (zh) * | 2012-10-25 | 2015-04-08 | 潜江永安药业股份有限公司 | 一种牛磺酸的制备方法 |
CN106728405A (zh) * | 2016-11-15 | 2017-05-31 | 陈思文 | 一种牛磺酸和水溶性茶多酚复方组合物及其制备方法与应用 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58140017A (ja) * | 1981-12-22 | 1983-08-19 | Junichi Azuma | 心不全治療剤 |
JPH08208464A (ja) * | 1994-12-02 | 1996-08-13 | Taisho Pharmaceut Co Ltd | 高脂血症の治療及び予防薬 |
US6184227B1 (en) * | 1995-07-21 | 2001-02-06 | Savvipharm Inc. | Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases |
SE9601395D0 (sv) * | 1996-04-12 | 1996-04-12 | Dieter Haeussinger | New therapeutic treatment 1 |
GB9722361D0 (en) * | 1997-10-24 | 1997-12-17 | Pharma Nord Uk Ltd | Pharmaceutical formulation for treating liver disorders |
NZ527924A (en) * | 1999-01-29 | 2005-01-28 | Mars Uk Ltd | Antioxidant compositions and methods for companion animals |
WO2001026642A2 (en) * | 1999-10-08 | 2001-04-19 | Joyce Corinne Bechthold | Methods and compositions for treating neurobehavioral disorders |
CN1340502A (zh) * | 2000-06-30 | 2002-03-20 | 张永春 | 牛磺酸合锌的生产工艺 |
CN1268733C (zh) * | 2004-07-20 | 2006-08-09 | 刘辉 | 牛磺酸功能啤酒及其生产工艺 |
-
2005
- 2005-12-31 MX MX2007008196A patent/MX2007008196A/es not_active Application Discontinuation
- 2005-12-31 CN CNA2005800460663A patent/CN101146767A/zh active Pending
- 2005-12-31 WO PCT/EG2005/000044 patent/WO2006072259A2/en active Application Filing
- 2005-12-31 EP EP05818935A patent/EP1844006A2/en not_active Withdrawn
- 2005-12-31 AP AP2007004084A patent/AP2007004084A0/xx unknown
- 2005-12-31 KR KR1020077016443A patent/KR20070091198A/ko not_active Application Discontinuation
- 2005-12-31 BR BRPI0519606-0A patent/BRPI0519606A2/pt not_active IP Right Cessation
- 2005-12-31 AU AU2005324199A patent/AU2005324199A1/en not_active Abandoned
- 2005-12-31 CA CA002593563A patent/CA2593563A1/en not_active Abandoned
- 2005-12-31 EA EA200701434A patent/EA200701434A1/ru unknown
- 2005-12-31 JP JP2007549796A patent/JP2008526789A/ja active Pending
-
2007
- 2007-06-14 TN TNP2007000226A patent/TNSN07226A1/fr unknown
- 2007-06-26 IL IL184221A patent/IL184221A0/en unknown
- 2007-07-26 MA MA30110A patent/MA29238B1/fr unknown
- 2007-09-28 NO NO20074937A patent/NO20074937A/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
MX2007008196A (es) | 2008-02-22 |
TNSN07226A1 (en) | 2008-11-21 |
IL184221A0 (en) | 2008-12-29 |
AP2007004084A0 (en) | 2007-08-31 |
CN101146767A (zh) | 2008-03-19 |
WO2006072259A2 (en) | 2006-07-13 |
WO2006072259A3 (en) | 2007-10-04 |
EP1844006A2 (en) | 2007-10-17 |
CA2593563A1 (en) | 2006-07-13 |
KR20070091198A (ko) | 2007-09-07 |
JP2008526789A (ja) | 2008-07-24 |
EA200701434A1 (ru) | 2008-10-30 |
NO20074937A (no) | 2007-09-28 |
AU2005324199A1 (en) | 2006-07-13 |
BRPI0519606A2 (pt) | 2009-02-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69628290T2 (de) | Methoden und zusammensetzungen zur lipidisierung hydrophiler moleküle | |
US5700830A (en) | Use of nitric oxide-releasing agents for reducing metastasis risk | |
CN102438978B (zh) | 聚胺衍生物 | |
BRPI0508854A (pt) | sais farmacêuticos de ácido-3-o-(3',3'-dimetilsuccinil) betulìnico | |
US7700080B2 (en) | Method of suppressing melanin production by metal chelates of lipoyl amino acid derivatives | |
EP3210633A3 (en) | Compositions and their uses directed to huntingtin | |
WO1997030170A1 (de) | Zusammensetzung für die transfektion höherer eukaryotischer zellen | |
BRPI0509468A (pt) | 1,3,4-oxadiazol-2-onas como modulares de ppar delta e usos das mesmas | |
ES2874862T3 (es) | Extracto antiinflamatorio de Boswellia frereana | |
MA29238B1 (fr) | Synthese de taurine, production et utilisation de celle-ci comme medicament | |
EP2316941A3 (en) | Compositions and their uses directed to IL-4R alpha | |
EP2308837A3 (en) | Derivatives of arylsulfonamido-substituted hydroxamic acid as matrix metalloproteinases inhibitors | |
EP1968606A4 (en) | PREPARATION OF PHARMACEUTICAL SALTS OF 3-O- (3 ', 3'-DIMETHYLSUCCINYL) BETULINIC ACID | |
WO2005055980A3 (en) | Polymalic acid-based multifunctional drug delivery system | |
WO2008013860A3 (en) | Acyloxyalkyl carbamate prodrugs of alpha-amino acids, methods of synthesis and use | |
FR2868775B1 (fr) | Nouveau procede de synthese de derives de la 1,3,4,5- tetrahydro-2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable | |
BR9915019A (pt) | Derivados de propanolamina ligados com ácido biliar para o tratamento de distúrbios do metabolismo de lipìdeos | |
Oiry et al. | Synthesis and biological evaluation in human monocyte-derived macrophages of N-(N-acetyl-L-cysteinyl)-S-acetylcysteamine analogues with potent antioxidant and anti-HIV activities | |
Wells et al. | Tris and the ready production of drug‐fatty acyl conjugates | |
WO2012061165A2 (en) | Methods and compositions for improving admet properties | |
KR102166268B1 (ko) | 피부장벽 기능 이상의 개선용 조성물 | |
JP2017071600A (ja) | くすぶり炎症抑制剤 | |
FR2868776B1 (fr) | Nouveau procede de synthese de derives de la 1,3-dihydro- 2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable | |
Salameh et al. | Prodrugs targeting the central nervous system (CNS) | |
AR051933A1 (es) | Proceso para la preparacion de n-(3,5 dicloropirid-4-ilo)-4-difluormetoxi-8-metano sulfonamido-dibenzo[b,d] furano-1-carboxamida |